IBDEI19H ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21091,1,3,0)
 ;;=3^Undifferntiated Somatoform Disorder
 ;;^UTILITY(U,$J,358.3,21091,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,21091,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,21092,0)
 ;;=97762^^100^1021^1^^^^1
 ;;^UTILITY(U,$J,358.3,21092,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21092,1,2,0)
 ;;=2^C/O For Orthotic/Prosth Use
 ;;^UTILITY(U,$J,358.3,21092,1,3,0)
 ;;=3^97762
 ;;^UTILITY(U,$J,358.3,21093,0)
 ;;=97760^^100^1021^2^^^^1
 ;;^UTILITY(U,$J,358.3,21093,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21093,1,2,0)
 ;;=2^Orthotic Mgmt and Training
 ;;^UTILITY(U,$J,358.3,21093,1,3,0)
 ;;=3^97760
 ;;^UTILITY(U,$J,358.3,21094,0)
 ;;=97761^^100^1021^3^^^^1
 ;;^UTILITY(U,$J,358.3,21094,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21094,1,2,0)
 ;;=2^Prosthetic Training
 ;;^UTILITY(U,$J,358.3,21094,1,3,0)
 ;;=3^97761
 ;;^UTILITY(U,$J,358.3,21095,0)
 ;;=97001^^100^1022^4^^^^1
 ;;^UTILITY(U,$J,358.3,21095,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21095,1,2,0)
 ;;=2^PT Evaluation
 ;;^UTILITY(U,$J,358.3,21095,1,3,0)
 ;;=3^97001
 ;;^UTILITY(U,$J,358.3,21096,0)
 ;;=97002^^100^1022^5^^^^1
 ;;^UTILITY(U,$J,358.3,21096,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21096,1,2,0)
 ;;=2^PT Re-Evaluation
 ;;^UTILITY(U,$J,358.3,21096,1,3,0)
 ;;=3^97002
 ;;^UTILITY(U,$J,358.3,21097,0)
 ;;=97003^^100^1022^1^^^^1
 ;;^UTILITY(U,$J,358.3,21097,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21097,1,2,0)
 ;;=2^OT Evaluation
 ;;^UTILITY(U,$J,358.3,21097,1,3,0)
 ;;=3^97003
 ;;^UTILITY(U,$J,358.3,21098,0)
 ;;=97004^^100^1022^2^^^^1
 ;;^UTILITY(U,$J,358.3,21098,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21098,1,2,0)
 ;;=2^OT Re-Evaluation
 ;;^UTILITY(U,$J,358.3,21098,1,3,0)
 ;;=3^97004
 ;;^UTILITY(U,$J,358.3,21099,0)
 ;;=97750^^100^1022^3^^^^1
 ;;^UTILITY(U,$J,358.3,21099,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21099,1,2,0)
 ;;=2^Physical Performance Test (KT Eval)
 ;;^UTILITY(U,$J,358.3,21099,1,3,0)
 ;;=3^97750
 ;;^UTILITY(U,$J,358.3,21100,0)
 ;;=G0151^^100^1023^7^^^^1
 ;;^UTILITY(U,$J,358.3,21100,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21100,1,2,0)
 ;;=2^PT in home/hospice,ea 15min
 ;;^UTILITY(U,$J,358.3,21100,1,3,0)
 ;;=3^G0151
 ;;^UTILITY(U,$J,358.3,21101,0)
 ;;=G0152^^100^1023^4^^^^1
 ;;^UTILITY(U,$J,358.3,21101,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21101,1,2,0)
 ;;=2^OT in home/hospice,ea 15min
 ;;^UTILITY(U,$J,358.3,21101,1,3,0)
 ;;=3^G0152
 ;;^UTILITY(U,$J,358.3,21102,0)
 ;;=G0157^^100^1023^8^^^^1
 ;;^UTILITY(U,$J,358.3,21102,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21102,1,2,0)
 ;;=2^PTA in home/hospice,ea 15min
 ;;^UTILITY(U,$J,358.3,21102,1,3,0)
 ;;=3^G0157
 ;;^UTILITY(U,$J,358.3,21103,0)
 ;;=G0158^^100^1023^5^^^^1
 ;;^UTILITY(U,$J,358.3,21103,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21103,1,2,0)
 ;;=2^OTA in home/hospice,ea 15min
 ;;^UTILITY(U,$J,358.3,21103,1,3,0)
 ;;=3^G0158
 ;;^UTILITY(U,$J,358.3,21104,0)
 ;;=G0159^^100^1023^6^^^^1
 ;;^UTILITY(U,$J,358.3,21104,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21104,1,2,0)
 ;;=2^PT Maint in home,ea 15min
 ;;^UTILITY(U,$J,358.3,21104,1,3,0)
 ;;=3^G0159
 ;;^UTILITY(U,$J,358.3,21105,0)
 ;;=G0160^^100^1023^3^^^^1
 ;;^UTILITY(U,$J,358.3,21105,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21105,1,2,0)
 ;;=2^OT Maint in home,ea 15min
 ;;^UTILITY(U,$J,358.3,21105,1,3,0)
 ;;=3^G0160
 ;;^UTILITY(U,$J,358.3,21106,0)
 ;;=G0161^^100^1023^9^^^^1
 ;;^UTILITY(U,$J,358.3,21106,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21106,1,2,0)
 ;;=2^SLP Maint in Home,Ea 15min
 ;;^UTILITY(U,$J,358.3,21106,1,3,0)
 ;;=3^G0161
